You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
先健科技(1302.HK)高開2.62% 髂動脈分叉支架系統獲NMPA批准上市
格隆匯 01-14 09:29
格隆匯1月14日丨先健科技(1302.HK)高開2.62%報5.1港元,最新市值236億港元。先健科技入選了格隆匯“2021 Tenbagger系列”。公司昨日公佈集團自主研發的Lifeflow™髂動脈分叉支架系統獲中國國家藥品監督管理局正式註冊批准。Lifeflow™用於腹髂動脈瘤或髂總脈瘤的治療,為我國自主研發並獲得註冊批准的首個腔內重建髂內動脈的器械。此次Lifeflow™髂動脈分叉支架系統獲批上市,豐富了先健科技外周血管介入產品組合,使先健科技進一步完善了其在主動脈腔內治療領域的平台性佈局。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account